How Long Does Benzos Stay in Urine?
Evidence-based answer reviewed against SAMHSA cutoffs and FDA assay documentation · Updated August 2026
Quick answer: Most people clear Benzos from urine within alprazolam/lorazepam: ~2–4 days of last use — heavy or daily use stretches that window substantially. Expanded-panel urine screens commonly at 300 ng/mL (oxazepam equivalent) with 200 ng/mL confirmation.
Benzos detection windows by test type
Each specimen tells a different story because each samples different biology:
| Test type | Typical Benzos detection window |
|---|---|
| Urine | short_acting: alprazolam/lorazepam: ~2–4 days; long_acting: diazepam/clonazepam: up to 10 days; weeks in long-term heavy users (nordiazepam accumulates) |
| Saliva (Mouth Swab) | any: 1–3 days |
| Hair Follicles | up to 90 days |
| Blood | any: 1–2 days |
('Urine remains the employment default because it balances cost, window-length and legal defensibility. Metabolite CONCENTRATIONS (not presence/absence) decide results against cutoff tables, which is why hydration status moves numbers and why validity checks (creatinine, specific gravity) police dilution attempts.',)
Why detection works this way
Benzos are not on the basic federal 5-panel, but they are included on most 10- and 12-panel employment screens. Whether your job tests for them depends entirely on panel size and employer policy.
Half-life drives detection: alprazolam averages ~11 hours while diazepam's active metabolite nordiazepam persists for 40–100+ hours, which is why diazepam outlasts alprazolam by a wide margin.
Legitimate prescriptions verify cleanly through the MRO. Bring proof to the collection or answer the follow-up call; unexplained positives become 'refusal-to-substitute' records in safety-sensitive programs.
Factors that stretch or shrink your window
- Frequency & dose — chronic use saturates stores; single use clears fastest.
- Body composition — some metabolites persist longer with higher body-fat percentages.
- Metabolism & hydration — concentration shifts with fluid intake; elimination speed does not.
- Potency & route — concentrates and edibles deliver more analyte than light use.
Testing cutoffs in plain language
Expanded-panel urine screens commonly at 300 ng/mL (oxazepam equivalent) with 200 ng/mL confirmation. A specimen under the initial cutoff reports negative without further work; a screen above cutoff gets confirmed by mass spectrometry before anyone sees a positive.
Planning ahead? Our at-home drug test guide covers retail kits that mirror lab screens.
Certified labs nationwide · Results in 1–2 days
Need a test? Order online, test same-day →People also ask
Does alprazolam Show up on a Drug Test?
No — Benzos is absent from standard drug panels. Full guide →
How Long Does alprazolam Show up on a Drug Test?
How long Benzos stays detectable in your system (all test types) — urine, hair, saliva & blood windows explained with cutoffs. Full guide →
How Long Does alprazolam Stay in Urine Drug Test?
How long Benzos stays detectable in urine — urine, hair, saliva & blood windows explained with cutoffs. Full guide →
Can Alprazolam Cause a False Positive Drug Test?
Can Benzos trigger a false positive? Cross-reactivity evidence, confirmation testing, and how to clear your name with the MRO. Full guide →
How Long Does alprazolam Stay in Urine Drug Test?
Urine detection runs roughly alprazolam/lorazepam: ~2–4 days after last use; hair extends to ~90 days and saliva stays within 24–72 hours. Full breakdown in our detection guides.
How Long Does alprazolam Stay in Urine for Drug Test?
Urine detection runs roughly alprazolam/lorazepam: ~2–4 days after last use; hair extends to ~90 days and saliva stays within 24–72 hours. Full breakdown in our detection guides.
Do prescriptions count against me?
No — verified prescriptions report as negative through the Medical Review Officer. Declare medications at collection and answer the follow-up call.
Sources & further reading
- SAMHSA — Mandatory Guidelines for Federal Workplace Drug Testing Programs (cutoffs, MRO process)
- DOT — 49 CFR Part 40 procedures for transportation workplace testing
- Brahm NC et al., Mayo Clinic Proceedings 2008;83(1):66–76 — false-positive cross-reactivity reference
- FDA — drug-of-abuse test device labeling (detection window conventions)